Hematopoetic cancer. Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
Conditions
Interventions
Intervention 1: Intervention group: aerobic and resistance exercise for 4 weeks in addition to standard pre-transplant treatment. Intervention 2: Control group: standard pre-transplant treatment witho
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: age :16-65 years old multiple myeloma or Hodgkin disease confirmed by pathology treatment option : autologous bone marrow transplantation willing to participation
Exclusion criteria
Exclusion criteria: no concomitant chronic disease (Hypertension, Diabetes, Chronic Kidney disease) concomitant orthopedic deficiency interrupting exercise not willing to do 14 aerobic exercise session in 4 weeks not willing to do 8 resistance exercise session in 4 weeks history of hemoglobin level less than 8 g/dl history of platelet less than 50000/microl History of fever and neutropenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone marrow sample WBC count for transplant. Timepoint: after 4 weeks of standard pre-transplant treatment ( control group) or 4 weeks exercise in addition to standard pre-transplant treatment ( intervention group). Method of measurement: the number of mononuclear and CD34 cells by the report of pathologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital admission length after transplant. Timepoint: after patients discharge. Method of measurement: admition days based on the hospital documentation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Bahar Hassanmirzaei
Shahid Beheshti University of Medical Sciences
Outcome results
None listed